Sayfa yüklenirken bir hata oluştu.
Teknik ekibimiz bilgilendirildi, ancak sorunun devam etmesi durumunda lütfen e-posta destek widget ile bize ulaşın.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM EBIT Multiple | -46,4x - -51,2x | -48,8x |
Selected Fwd EBIT Multiple | -87,9x - -97,1x | -92,5x |
Fair Value | ₩4.810 - ₩6.215 | ₩5.513 |
Upside | -46,7% - -31,1% | -38,9% |
Benchmarks | Ticker | Full Ticker |
Huons Global Co., Ltd. | A084110 | KOSDAQ:A084110 |
Ilyang Pharmaceutical Co.,Ltd | A007570 | KOSE:A007570 |
Kyung Dong Pharmaceutical Co., Ltd. | A011040 | KOSDAQ:A011040 |
Dongwha Pharm.Co.,Ltd | A000020 | KOSE:A000020 |
JW Lifescience Corporation | A234080 | KOSE:A234080 |
Jeil Pharma Holdings Inc | A002620 | KOSE:A002620 |
- | - | - |
Select LTM EBIT Multiple | |||||||
Benchmark Companies | |||||||
A084110 | A007570 | A011040 | A000020 | A234080 | A002620 | ||
KOSDAQ:A084110 | KOSE:A007570 | KOSDAQ:A011040 | KOSE:A000020 | KOSE:A234080 | KOSE:A002620 | ||
Historical EBIT Growth | |||||||
5Y CAGR | 6.0% | -19.5% | -36.1% | 7.1% | 3.8% | NM- | |
3Y CAGR | 8.5% | -10.2% | -45.0% | -15.8% | 8.1% | NM- | |
Latest Twelve Months | -16.0% | -11.7% | 122.8% | -29.8% | 19.2% | -257.9% | |
Historical EBIT Profit Margin | |||||||
5 Year Average Margin | 14.3% | 6.4% | 2.5% | 6.8% | 16.6% | 0.3% | |
Prior Fiscal Year | 15.3% | 6.1% | -15.3% | 5.2% | 14.9% | 2.6% | |
Latest Fiscal Year | 12.0% | 4.1% | 1.4% | 2.9% | 16.1% | -1.4% | |
Latest Twelve Months | 12.0% | 4.5% | 2.5% | 1.9% | 15.0% | -0.6% | |
Current Trading Multiples | |||||||
EV / LTM Revenue | 1.12x | 1.13x | 0.50x | 0.47x | 0.95x | 0.35x | |
EV / LTM EBITDA | 6.6x | 14.1x | 9.9x | 7.4x | 4.4x | 27.7x | |
EV / LTM EBIT | 9.4x | 24.8x | 19.8x | 24.2x | 6.3x | -61.6x | |
Low | Mid | High | |||||
Benchmark EV / LTM EBIT | 6.3x | 19.8x | 24.8x | ||||
Historical EV / LTM EBIT | -26.8x | 21.1x | 95.7x | ||||
Selected EV / LTM EBIT | -46.4x | -48.8x | -51.2x | ||||
(x) LTM EBIT | (4,342) | (4,342) | (4,342) | ||||
(=) Implied Enterprise Value | 201,283 | 211,876 | 222,470 | ||||
(-) Non-shareholder Claims * | (131,091) | (131,091) | (131,091) | ||||
(=) Equity Value | 70,192 | 80,786 | 91,380 | ||||
(/) Shares Outstanding | 15.4 | 15.4 | 15.4 | ||||
Implied Value Range | 4,572.44 | 5,262.54 | 5,952.64 | ||||
FX Rate: KRW/KRW | 1.0 | 1.0 | 1.0 | Market Price | |||
Implied Value Range (Trading Cur) | 4,572.44 | 5,262.54 | 5,952.64 | 9,020.00 | |||
Upside / (Downside) | -49.3% | -41.7% | -34.0% |
Equity Waterfall | |||||||
Benchmark Companies | |||||||
(in millions) | A084110 | A007570 | A011040 | A000020 | A234080 | A002620 | |
Enterprise Value | 912,477 | 309,315 | 100,445 | 221,421 | 233,426 | 269,558 | |
(+) Cash & Short Term Investments | 289,382 | 13,036 | 32,582 | 39,654 | 26,465 | 70,550 | |
(+) Investments & Other | 98,869 | 44,051 | 68,323 | 60,156 | 2,062 | 93,363 | |
(-) Debt | (285,581) | (114,649) | (36,205) | (103,805) | (65,299) | (160,796) | |
(-) Other Liabilities | (454,511) | (3,721) | (261) | (26,958) | 0 | (134,207) | |
(-) Preferred Stock | (7,054) | (1,113) | 0 | (1,154) | 0 | 0 | |
(-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
Value of Common Equity | 553,582 | 246,919 | 164,884 | 189,313 | 196,654 | 138,467 | |
(/) Shares Outstanding | 12.2 | 18.0 | 26.9 | 27.7 | 15.5 | 15.4 | |
Implied Stock Price | 45,450.00 | 13,740.00 | 6,120.00 | 6,830.00 | 12,700.00 | 9,020.00 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 45,450.00 | 13,740.00 | 6,120.00 | 6,830.00 | 12,700.00 | 9,020.00 | |
Trading Currency | KRW | KRW | KRW | KRW | KRW | KRW | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |